BioCentury | Nov 3, 2017
Company News
Zealand and Orbit in peptide discovery deal
...In September, gastrointestinal and metabolic disease company Zealand Pharma A/S (CSE:ZEAL; NASDAQ:ZEAL) and Orbit Discovery (Oxford, U.K...
...Orbit Discovery Ltd., Oxford, U.K. Zealand Pharma A/S (CSE:ZEAL; NASDAQ:ZEAL), Glostrup, Denmark Business: Endocrine/Metabolic, Gastrointestinal Shannon Lehnbeuter Zealand Pharma A/S Orbit Discovery...
...Orbit Discovery Ltd., Oxford, U.K. Zealand Pharma A/S (CSE:ZEAL; NASDAQ:ZEAL), Glostrup, Denmark Business: Endocrine/Metabolic, Gastrointestinal Shannon Lehnbeuter Zealand Pharma A/S Orbit Discovery...
